There are limited experiences with overdose with avelumab in clinical studies. In case of overdose, patients should be closely monitored for signs or symptoms of adverse reactions. The treatment is directed to the management of symptoms.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.